Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Achaogen Inc AKAOQ

Healthcare Biotechnology
"Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States."


OTCPK:AKAOQ - Post by User

Achaogen Inc
Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by BluSignalson Jun 26, 2018 1:48pm
100 Views
Post# 28231316

AKAO Leading Indicators

AKAO Leading IndicatorsAKAO leading indicators predicted today's fall of 21% almost 1 month ago. 

The predictions were based on a combination of variables.  Stock price, volume, product demand and the earnings all added up.  Even though much is attributed to the FDA's decision not to approve their new drug, other indications were also a part of the current turn.  #BluSignals

https://www.blusignalsystems.com/akao-stock-falls-while-leading-indicators-alert-traders/
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities